Zoloft (sertraline HCl) tablets 25 mg* 30-count bottle, Rx only, Distributed by Roerig Division of Pfizer Inc., NY, NY, 10017 NDC 0049-4960-30
FDA recall notice · announced January 10, 2018 · Pfizer
Class I FDA/FSIS Class I: reasonable probability that use will cause serious adverse health consequences or death.
The product
Zoloft (sertraline HCl) tablets 25 mg* 30-count bottle, Rx only, Distributed by Roerig Division of Pfizer Inc., NY, NY, 10017 NDC 0049-4960-30
Reason for recall
SUPERPOTENT: Weight variations resulting in tablets that are sub and super potent
Notes
Distribution: Nationwide in the USA
Lot/code information: Lot: S84026
Quantity: 1972 bottles
Status: Terminated
Products in this recall event:
- diphenoxylate hydrochloride and atropine sulfate tablets, USP, 2.5 mg/0.025 mg, a) 100-count bottle (NDC 59762-1061-1), b) 1000-count bottle (NDC 59762-1061-2), Rx Only, Distributed by: Greenstone LLC (D-0150-2018)
- Zoloft (sertraline HCl) tablets 25 mg* 30-count bottle, Rx only, Distributed by Roerig Division of Pfizer Inc., NY, NY, 10017 NDC 0049-4960-30 (D-0151-2018)
Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.